Skip to main content
Clinical Trials/NCT02060565
NCT02060565RecruitingNot Applicable

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.

Association HGE CHU Bordeaux Sud1 site in 1 country10,000 target enrollmentStarted: February 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10,000
Locations
1
Primary Endpoint
Overall survival

Study Overview

Brief Summary

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Detailed Description

All consecutive patients with chronic liver disease will be followed during 20 years.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • chronic hepatitis C
  • chronic hepatitis B
  • alcohol liver disease
  • non alcoholic liver disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Overall survival

Time Frame: 20 years

Secondary Outcomes

  • Survival without liver complications(20 years)

Investigators

Sponsor
Association HGE CHU Bordeaux Sud
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials